MedWatch

Genmab raises guidance ahead of annual report

Sales of the Genmab-developed cancer drug Darzalex have been so strong throughout 2016 that the biotech is raising its financial guidance for 2016 just a few weeks before the publication of the annual report.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

Dansk epilepsialarm er blevet solgt til USA

Selskabet Ictalcare, der har Coloplast i ejerkredsen og har udviklet en særlig epilepsialarm, har solgt sine aktiver til et amerikansk selskab. Det er konklusionen på en strategisk proces, som har varet i flere år.

Latest Top picks in English

Related articles